No description
-
2017 (v1)PublicationUploaded on: April 14, 2023
-
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2016 (v1)PublicationFight against H1N1 Influenza A Virus: Recent Insights towards the Development of Druggable Compounds
No description
Uploaded on: March 27, 2023 -
2017 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2017 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2009 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2009 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2008 (v1)Publication
Two series of ()-2-phenyl-1-(quinolizidin-1α-yl)benzimidazoles, 12A–26A, and ()-2-phenyl-1- (quinolizidin-1β-yl)benzimidazoles, 12B–26B, were prepared and tested for the inhibition of human platelets aggregation induced by ADP, collagen, and adrenaline. All epimers A, i.e., 12A–26A, were devoid of any activity against the three agonists, while...
Uploaded on: April 14, 2023 -
2017 (v1)Publication
The 5-hydroxytryptamine (5-HT1A) receptors represent an attractive target in drug discovery. In particular, 5-HT1A agonists and partial agonists are deeply investigated for their potential role in the treatment of anxiety, depression, ischaemic brain disorder and more recently, of pain. On the other hand, 5-HT1A antagonists have been revealed...
Uploaded on: April 14, 2023